Real ChatGPT answer · index seedMbHwxBlKjDQcompleteHealth and wellness · common conditions and symptomscomparison
Is berberine actually as effective as low dose rosuvastatin for lowering LDL cholesterol in patients with statin intolerance?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Is berberine actually as effective as low dose rosuvastatin for lowering LDL cholesterol in patients with statin intolerance?
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
berberine LDL cholesterol randomized trial meta-analysis statin intolerance rosuvastatin low dose comparison Google ↗
rosuvastatin 5 mg LDL reduction dose response statin intolerance guidelines nonstatin therapy berberine cardiovascular outcomes Google ↗
- Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. · pubmed.ncbi.nlm.nih.gov
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · ahajournals.org
- The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis · pmc.ncbi.nlm.nih.gov
- Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance · pubmed.ncbi.nlm.nih.gov
- Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance · pmc.ncbi.nlm.nih.gov
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · doi.org
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · doi.org
- 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 | Diabetes Care · doi.org
- 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee · jacc.org
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
berberine LDL cholesterol randomized trial meta-analysis statin intolerance rosuvastatin low dose comparison OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
rosuvastatin 5 mg LDL reduction dose response statin intolerance guidelines nonstatin therapy berberine cardiovascular outcomes OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |